HOUSTON, December 24, 2018-- BrainCheck, a Texas-based digital neurocognitive testing platform, has raised $1.5 million in additional capital to bring AI and personalized medicine to dementia care through its cognitive care management technology, BrainCheck Care, which launched in July 2018. Funding, led by True Wealth Ventures, with participation from Tensility Venture Partners, XFactor Ventures, S3 Ventures and angel investors, brings the total funding to $6 million to date. Born at the Eagleman Neuroscience Laboratory at Baylor College of Medicine (now at Stanford), BrainCheck enables physicians to rapidly and accurately assess cognitive function and deliver cognitive care at scale.